Holen Sie sich die Stockscreener-App
82.67
0.15%
-0.07
Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten
LNTH Maintained by Mizuho -- Price Target Raised to $95 - GuruFocus
Riley Maintains ‘Buy’ Rating on Lantheus Holdings, Inc. (LNTH); Lowers PT - MSN
Lantheus Holdings, Inc. Cash Ratio | LNTH - MLQ.ai
What are the future prospects of Lantheus Holdings IncPortfolio Profit Report & Safe Entry Momentum Tips - baoquankhu1.vn
How (LNTH) Movements Inform Risk Allocation Models - Stock Traders Daily
Lantheus Holdings Inc stock (US5156731020): Is its radiopharma dominance strong enough to unlock new - AD HOC NEWS
Bear Alert: Is Lantheus Holdings Inc exposed to political riskIPO Watch & Verified Momentum Stock Alerts - baoquankhu1.vn
A Look At Lantheus Holdings (LNTH) Valuation As Cautious Sentiment Follows Expected Sales And Margin Pressure - Yahoo Finance
Lantheus Holdings trying to close in on key technical measure - MSN
William Blair and Jefferies Maintain Outperform/Buy on Lantheus (LNTH) March 2026 - Meyka
Lantheus Holdings: Tensions From The PDUFA Extension (NASDAQ:LNTH) - Seeking Alpha
LNTH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 48% Share Price Bounce - 富途牛牛
LANTHEUS HOLDINGS INC (1LNTH.MI) options chain - Yahoo Finance Australia
Lantheus Holdings, Inc. (LNTH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Forecast Cut: Whats the MACD signal for Lantheus Holdings Inc2026 Support & Resistance & Detailed Earnings Play Strategies - baoquankhu1.vn
LNTH Stock Price, Quote & Chart | LANTHEUS HOLDINGS INC (NASDAQ:LNTH) - ChartMill
Lantheus (NASDAQ: LNTH) CCO logs PSU vesting, tax withholding - Stock Titan
Lantheus Holdings, Inc. (LNTH) Stock Forecasts - Yahoo Finance
Lantheus Holdings, Inc. (LNTH) stock price, news, quote and history - Yahoo Finance UK
Bronstein, Gewirtz & Grossman, LLC Encourages Lantheus Holdings, Inc. (LNTH) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Jefferies Lifts PT on Lantheus Holdings (LNTH) to $110 From $105 – Here’s Why - Insider Monkey
Trading Systems Reacting to (LNTH) Volatility - Stock Traders Daily
Risk Analysis: How does Lantheus Holdings Inc compare to its peersEarnings Summary Report & AI Enhanced Trading Signals - baoquankhu1.vn
Portfolio Update: What analysts say about Lantheus Holdings Inc stockGDP Growth & Safe Entry Momentum Tips - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Shareholders to Connect - ACCESS Newswire
Assenagon Asset Management S.A. Trims Position in Lantheus Holdings, Inc. $LNTH - MarketBeat
11 High Growth Healthcare Stocks to Buy Now - Insider Monkey
Lantheus says FDA extended review period for radioactive diagnostic kit - MSN
Lantheus (NASDAQ:LNTH) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Vanguard disaggregates holdings; Vanguard subsidiaries to report LNTH positions (LNTH) - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Shareholders to Reach Out - ACCESS Newswire
Insider Buy: Is Lantheus Holdings Inc exposed to political risk2026 Recap & Safe Entry Point Alerts - baoquankhu1.vn
FDA Delays Decision on LNTH-2501 in Neuroendocrine Tumors - Targeted Oncology
William Blair, Jefferies Maintain LNTH Lantheus Holdings March 2026: Outperform Buy - Meyka
Nuclear Medicine (Radiopharmaceuticals) Market Set for Strong Growth at 9.50% CAGR Through 2034: DelveInsight | Lantheus, GE Healthcare, Novartis, Sotera Health and Others - Barchart.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lantheus Holdings, Inc. (LNTH) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
LNTH SEC FilingsLantheus Holding 10-K, 10-Q, 8-K Forms - Stock Titan
CWA Asset Management Group LLC Makes New $1.67 Million Investment in Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus Holdings, Inc. (LNTH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Lantheus to sell SPECT Business to SHINE Technologies - MSN
LNTH Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges LNTH Investors with Losses to Contact the Firm - The National Law Review
Class Action Announcement for Lantheus Holdings, Inc. Investors - The National Law Review
Form DEF 14A LANTHEUS HOLDINGS For: 20 March - Investing.com
Lantheus Holdings, Inc. ($LNTH) Former CEO 2025 Pay Revealed - Quiver Quantitative
[ARS] Lantheus Holdings, Inc. SEC Filing - Stock Titan
Lantheus (NASDAQ: LNTH) 2026 proxy outlines board elections, pay and equity plan - Stock Titan
How Lantheus Holdings Inc. (LNTH) Affects Rotational Strategy Timing - Stock Traders Daily
Lantheus Holdings Inc (LNTH) Trading Down 3.37% on Mar 19 - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Connect - ACCESS Newswire
Aug Weekly: Will Lantheus Holdings Inc outperform the market in YEAR2026 Key Highlights & Scalable Portfolio Growth Methods - baoquankhu1.vn
Why Lantheus Holdings Stock Popped by Almost 12% Last Month - AOL.com
Lantheus price target raised to $82 from $80 at Truist - MSN
Lantheus Holdings Q4 2025 earnings preview - MSN
Citizens reiterates Lantheus stock rating after FDA extends review By Investing.com - Investing.com Canada
FDA extends review of Lantheus’ neuroendocrine tumor drug By Investing.com - Investing.com South Africa
Lantheus says FDA pushed deadline for reviewing its tumor diagnostic kit application - MSN
Lantheus Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Lantheus stock holds Outperform at William Blair after FDA delay By Investing.com - Investing.com India
US FDA extends review of Lantheus’ diagnostic imaging kit by three months - WKZO
Lantheus stock holds Outperform at William Blair after FDA delay - Investing.com
1.68%
0.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):